IJSTR

International Journal of Scientific & Technology Research

IJSTR@Facebook IJSTR@Twitter IJSTR@Linkedin
Home About Us Scope Editorial Board Blog/Latest News Contact Us
CALL FOR PAPERS
AUTHORS
DOWNLOADS
CONTACT
QR CODE
IJSTR-QR Code

IJSTR >> Volume 8 - Issue 3, March 2019 Edition



International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616



Clarithromycin Resistance And Genetic Pattern Of Helicobacter Pylori In A Group Of Patients With Peptic Ulcer Disease In Alexandria, Egypt

[Full Text]

 

AUTHOR(S)

Mohamed A Alhammad, Hadir EL-Kady, Yaman Hamed

 

KEYWORDS

H. pylori, PUD, genotyping, CagA, VacA, 23S Rrna, clarithromycin resistance, multiplex PCR, real-time PCR

 

ABSTRACT

Clarithromycin resistance is one of the main predictors of eradication treatment failure in Helicobacter pylori (H. pylori) infections. Clarithromycin-based regimens were commonly used as a first-line therapy for H. pylori-positive patients. Lately, cure rates of H. pylori infection are decreasing to as low as 60% and are inversely correlated with antibiotic resistance rates that have crossed the 15-20% threshold. Monitoring of antibiotic susceptibility of H. pylori can be achieved through molecular methods; which stand out as an attractive alternative to conventional culture-based methods. The 23S rRNA Real-time PCR has several advantages in detection of H. pylori resistance to antibiotics; such as short working time, a high specificity up to 100% and low risk of contamination. This study aimed to detect clarithromycin resistance and genetic pattern of H. pylori in a group of 50 patients suffering from symptoms suggestive of gastrointestinal diseases. Gastric biopsy specimens were taken by endoscopy at the Gastroenterology Department of Alexandria Main University Hospital. Genotyping of H. pylori strains using multiplex PCR to detect CagA and VacA genes and detection of point mutations conferring clarithromycin resistance using a 23 S rRNA real time PCR was carried out. The majority (98%) of H. pylori strains detected in patients were CagA positive while only 28/50 (56%) were VacA positive. Most of the strains (67.86%) expressed the s2 (non toxigenic) allele and the most common genotype was VacA s2m1; expressed by 39.3% of strains. All H. pylori strains of the control group were sensitive to clarithromycin while resistance was detected in 26% of strains recovered from cases. The majority (77%) of point mutations responsible for resistance to clarithromycin were due to A-G transition at position 2143 while only 23% of which were due to A-C transition at position 2142.

 

REFERENCES

[1] Y.Thaker, A. Moon and A. Afzali. "Helicobacter pylori:A Review of Epidemiology,Treatment,and Management, " J. Clin. Gastroenterol. Treat., vol. 2, no. 2, pp.019, 2016.

[2] S. Shiota and Y. Yamaoka. "Strategy for the treatment of Helicobacter pylori infection," Curr. Pharm. Des., vol. 20, no. 28, pp.4489 – 4500, 2014.

[3] V. Shetty, M. Ballal, R, Lingadakai and A. Mukhopadhyay. "Determination of Helicobacter pylori Virulence Genes in Clinical Isolates of Symptomatic Patients from South Coastal Region of Karnataka – A Preliminary Work". Austin J. Gastroenterol., vol. 2, no. 1, pp.1031, 2015.

[4] A.S.M. Ali, I.M.S. Al-Kadmy, M.R. Ali, S.S. Al-Jubori. "Emergency of Helicobacter pylori resistance isolates obtained from Iraqi patients suffering Acute and chronic gastritis, " World J. Pharm. Sci. vol. 4, no. 7, pp. 18 – 23, 2016.

[5] S. Alaoui Boukhris, A. Amarti, K. El Rhazi, M. El Khadir, D.A. Benajah, S.A. Ibrahimi, C. Nejjari, M. Mahmoud, A. Souleimani and B. Bennani. "Helicobacter pylori Genotypes Associated with Gastric HistoPathological Damages in a Moroccan Population," PLoS ONE, vol. 8, no. 12, pp. e82646, 2013.

[6] P. Malfertheiner, F. Megraud, C.A. O’Morain, J.P. Gisbert, E.J. Kuipers, A.T. Axon, F. Bazzoli, A. Gasbarrini, J. Atherton, D.Y. Graham, R. Hunt, P. Moayyedi, T. Rokkas, M. Rugge, M. Selgrad, S. Suerbaum, K. Sugano and E.M. El-Omar. "European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report". Gut, vol. 66, pp. 6-30, 2017.
[7] N. Toshihiro, S. Hidekazu and H. Toshifumi. "Quinolones-Based third-line therapy for Helicobacter pylori eradication". J. Clin. Biochem. Nutr., vol. 44, no. 3,pp.119 – 124, Mar 2009.

[8] R. Ghotaslou, H.E. Leylabadlo and Y.M. Asl. " Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review". World J. Methodol.,vol.5, no.3, pp.164 – 174, Sep. 2015.

[9] D. Boltin, H, Ben-Zvi, T.T. Perets, Z. Kamenetsky, Z. Samra, R. Dickman and Y. Niv. "Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned," J. Clin. Microbiol., vol. 53, pp. 522 – 527, 2015.

[10] V. Papastergiou, S.D. Georgopoulos and S. Karatapanis. "Treatment of Helicobacter pylori infection: Past, present and future," World J. Gastrointest. Pathophysiol. vol. 5, pp. 392 – 399, 2014.

[11] Y-T Chu, Y-H. Wang, J-J. Wu, H-Y. Lei. "Invasion and multiplication of Helicobacter pylori in gastric epithelial cells and implications for antibiotic resistance," Infect. Immun. Vol. 78, no. 10, pp. 4157 – 4165, 2010.

[12] M. Kargar, S. Ghorbani-Dalini, A. Doosti and N. Souod. "Real-time PCR for Helicobacter pylori quantification and detection of clarithromycin resistance in gastric tissue from patients with gastrointestinal disorders," Res. Microbiol. Vol. 163, pp. 109 – 113, 2012.

[13] V. De Francesco, F. Giorgio, C. Hassan, G. Manes, L. Vannella and C. Panella. "Worldwide H. pylori antibiotic resistance: a systematic review," J. Gastrointestin. Liver Dis., vol. 19, pp. 409 – 414, Dec.2010.

[14] M. Bakri. "Prevalence of Helicobacter pylori infection and the incidence of urea and clarithromycin resistance gene 23S rRNA genotypes status in Saudi Arabia," Saudi. J. Biol. Sci., vol. 20, no, 1, pp. 75 – 78, 2013.

[15] R. Rana, S.L.Wang, J. Li, Y.X. Wang, Q.W. Rao and C.Q. Yang. "Helicobacter pylori infection: A recent approach to diagnosis and management". J. Biomed.,vol. 2, pp. 45 – 56, 2017.

[16] J.J. Redondo, P.M. Keller, R. Zbinden and K. Wagner. (2018). "A novel RTPCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene," Diagn. Microbiol. Infect. Dis., vol. 90, no. 1, pp. 1 – 6, 2018.

[17] Y. Zhang, F. Zhao, M. Kong, S. Wang, L. Nan, B. Hu, M.A. Olszewski, Y. Miao, D. Ji, W. Jiang, Y. Fang, J. Zhang, F. Chen, P. Xiang, Y. Wu and H. Zhao. "Validation of a high-throughput multiplex genetic detection system for Helicobacter pylori identification, quantification, virulence, and resistance analysis," Front. Microbiol., vol. 7, pp. 1401, 2016.

[18] C. Albaa, A. Blancoa and T. Alarco. "Antibiotic resistance in Helicobacter pylori," Curr. Opin. Infect. Dis. vol. 30, pp. 489 – 497, 2017.

[19] C. Schabereiter-Gurtner, A.M. Hirschl, B. Dragosics, P. Hufnagl, S. Puz, Z. Kova´ch, M. Rotter and A. Makristathis. "Novel Real-Time PCR Assay for Detection of Helicobacter pylori Infection and Simultaneous Clarithromycin Susceptibility Testing of Stool and Biopsy Specimens," J. Clin. Microbiol.,vol. 42, no. 10, pp. 4512 – 4518, Oct. 2004.

[20] ABON Biopharm Co., 2012. ACON H. Infectious disease antigen detection. China: ABON BIOPHARM (HANGZHOU) CO., LTD. available from: http://www.abon.com.cn/Product/Index/ 15080715055791.

[21] O. Secka, M. Antonio, M. Tapgun, D.E. Berg, C. Bottomley, V. Thomas, R. Walton, T. Corrah, R.A. Adegbola and J.E. Thomas. "PCR-based genotyping of Helicobacter pylori of Gambian children and adults directly from biopsy specimens and bacterial cultures," Gut. Pathog. Vol. 3, no. 1, pp. 5, 2011.

[22] IBM Corp. Released 2016. IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp .

[23] D.C. Angol, P. Ocama, T. Ayazika Kirabo, A. Okeng, I. Najjingo and F. Bwanga. "Helicobacter pylori from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on Stool," BioMed. Res. Int. Vol. 2017, pp. 5430723, 2017.

[24] S.G. Kim, H.K. Jung, H.L. Lee, J.Y. Jang, H. Lee, C.G. Kim, W.G. Shin, E.S. Shin and Y.C. Lee. "Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea,". J. gastroenterol. hepatol. Vol. 29, pp. 1371 – 1386, 2014.

[25] P. Kjaeldgaard, A.P. Nielsen and M. Chen. Real Time PCR assay for detection of Helicobacter pylori infection and clarithromycin susceptibility in biopsy specimens in southern Denmark," JSM. Gastroenterol. Hepatol. vol. 4, no. 1, pp. 1052, 2016.

[26] R. Monno, F. Giorgio, P. Carmine, L. Soleo, V. Cinquepalmi and E. Ierardi. "Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study," APMIS, vol. 120, pp. 712 – 717, 2012.

[27] Y.K. Wang, F.C. Kuo, C.J. Liu, M.C. Wu, H.Y. Shih, S.S. Wang, J.Y. Wu, C.H. Kuo, Y.K. Huang and D.C. Wu. "Diagnosis of Helicobacter pylori infection: Current options and developments," World J. Gastroenterol. Vol. 21, no. 40, pp. 11221 – 11235, 2015.

[28] S. Wang, W-M. Zhang and E. Reineks. "Breath Tests for Detection of Helicobacter pylori and Aspergillus fumigatus," Advanced Techniques in Diagnostic Microbiology, Y.-W. Tang and C.W. Stratton, eds., New York: Springer Science Business Media, pp.13 -30, 2013.

[29] M. Diab, A. El-Shenawy, M. El-Ghannam, D. Salema, M. Abdelnasser, M. Shaheen, M. Abdel-Hady, E. El-Sherbini and M. Saber. "Detection of antimicrobial resistance genes of Helicobacter pylori strains to clarithromycin, metronidazole, amoxicillin and tetracycline among Egyptian patients," Egypt. j. med. hum. genet, vol.19, pp. 417–423, 2018.

[30] M.S. Zaki, A. Elewa, M.A. Ali and A. Shehta. "Study of Virulence Genes Cag A and Vac A in Helicobacter pylori Isolated from Mansoura University Hospital Patients by Multiplex PCR", Int. J. Curr. Microbiol. App. Sci., vol. 5, no. 2, pp. 154 – 160, 2016.

[31] F.A. Amer, R.H. El-Sokkary, M. Elahmady, T. Gheith, E.H. Abdelbary, Y. Elnagar and W.M. Abdalla. "Helicobacter pylori genotypes among patients in a university hospital in Egypt: identifying the determinants of disease severity, " JMID, vol. 3, pp. 109 – 115, 2013.

[32] N.R. Hussein. "Helicobacter pylori and gastric cancer in the Middle East: A new enigma?," World J. Gastroenterol. 2010;16:3226–3234.

[33] R. González-Vázquez, S. Herrera-González, M.G. Cordova-Espinoza, G. Zúńiga, S. Giono-Cerezo, J.M. Hernández-Hernández, G. León-Ávila. " Helicobacter pylori: detection of iceA1 and iceA2 genes in the same strain in Mexican isolates, " Arch. Med. Res. Vol. 43, no. 5, pp. 339 – 346, 2012.

[34] S. Maeda, K. Ogura, H. Yoshida, F. Kanai, T. Ikenoue, N. Kato, Y, Shiratori, M. Omata. " Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan," Gut, vol. 42, no. 3, pp. 338 – 343, 1998.

[35] J.Yakoob, S.Abid, Z.Abbasetal." Distribution of Helicobacter pylori virulence markers in patients with gastroduodenal diseases in Pakistan," BMC. Gastroenterol., vol. 9, no 87, pp. 1–7, 2009.

[36] T. Essawi, W. Hammoudeh, I. Sabri, W. Sweidan and M.A. Farraj. "Determination of Helicobacter pylori virulence genes in gastric biopsies by PCR," ISRN. Gastroenterol. Vol. 2013, pp. 606258, 2013.

[37] H.B. Pandya, H.H. Agravat and J.S. Patel. Prevalence of Specific Helicobacter Pylori CagA, VacA, iceA, UreC Genotypes and its Clinical Relevance in the Patients with Acid-Peptic Diseases. J. Clin. Diagn. Res. vol. 11, no. 8, pp. DC23-DC26, 2017.

[38] Y. Saeidi, A. Pournajaf, M. Gholami, M. Hasannejad-Bibalan, S. Yaghoubi, M. Khodabandeh, B. Emadi, E. Ferdosi-Shahandashti and R. Rajabnia. "Determination of Helicobacter pylori virulence-associated genes in duodenal ulcer and gastric biopsies," Med. J. Islam. Repub. Iran. vol. 31, pp. 95, 2017.

[39] A.F. Diab, F.H. Diab and S.S. Nassar. " Prevalence of Helicobacter pylori resistance to clarithromycin determined by 23S ribosomal RNA analysis in Jordan, " IAJAA, vol. 6, no. 2,pp. 4, 2016.

[40] Y. Li, E. Rimbara, S. Thirumurthi, A. Trespalacios, R. Reddy, S. Sabounchi, T.A. Attumi, D.Y. Graham. "Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days, " J. Dig. Dis., vol. 13, no. 1, pp. 54 – 59, Jan. 2012.

[41] T. Nishizawa, T. Maekawa, N. Watanabe, N. Harada, Y. Hosoda, M. Yoshinaga, T. Yoshio, H. Ohta, S. Inoue, T. Toyokawa, H. Yamashita, H. Saito, T. Kuwai, S. Katayama, E. Masuda, H. Miyabayashi, T. Kimura, Y. Nishizawa, M. Takahashi and H. Suzuki. " Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: a multicenter, prospective, randomized controlled study in Japan," J. Clin. Gastroenterol. Vol. 49, no. 6, pp. 468 – 471, 2015.

[42] K. Sugano, J. Tack, E.J. Kuipers, D.Y. Graham, E.M. El-Omar, S. Miura, K. Haruma, M. Asaka, N. Uemura and P. Malfertheiner." Kyoto global consensus report on Helicobacter pylori gastritis," Gut, vol. 64, pp. 1353 – 1367, 2015.

[43] N. Stollman. " Helicobacter pylori Infection in the Era of Antibiotic Resistance, " Gastroenterol. Hepatol. vol. 12, no. 2, pp. 122 – 125, 2016.

[44] World Health Organization (WHO), "Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics", Geneva: WHO, 2017.

[45] T. P. Van Boeckel, S. Gandra, A. Ashok, Q. Caudron, B. T. Grenfell, S. A. Levin, and R. Laxminarayan, "Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data", Lancet. Infect. Dis., vol. 14, pp. 742-750, Aug 2014.

[46] I. Thung, H. Aramin, V. Vavinskaya, S. Gupta, J.Y. Park, S.E. Crowe and M.A. Valasek, "Review article: the global emergence of Helicobacter pylori antibiotic resistance," Aliment. Pharmacol. Ther., vol. 43, pp. 514-533, Feb 2016.

[47] T. Champathai, S. Gonlachanvit and N. Chaichanawongsaroj, "Detection of A2143Gmutation in23S rRNA geneassociated with clarithromycinresistant H. pylori by Loop mediated isothermal amplification", J. Chem. Pharmac. Res., vol. 6, pp.148-155, 2014.

[48] A. Ducournau, L. Benejat, E. Sifre, E. Bessede, P. Lehours, and F. Megraud, "Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods," Clin. Microbiol. Infect., vol. 22, pp. 715-718, Aug 2016.

[49] D. Chen, S.A. Cunningham, N.C. Cole, P.C. Kohner, J.N. Mandrekar, and R. Patel, "Phenotypic and Molecular Antimicrobial Susceptibility of Helicobacter pylori," Antimicrob. Agents. Chemother., vol. 61, Apr 2017.

[50] S.A. Chisholm and R.J. Owen, "Application of polymerase chain reaction-based assays for rapid identification and antibiotic resistance screening of Helicobacter pylori in gastric biopsies," Diagn. Microbiol. Infect. Dis., vol. 61, pp. 67-71, May 2008.

[51] A.K. Lins, R.A. Lima, and M. Magalhaes, "Clarithromycin-resistant Helicobacter pylori in Recife, Brazil, directly identified from gastric biopsies by polymerase chain reaction," Arq. Gastroenterol, vol. 47, pp. 379-382, Oct-Dec 2010.

[52] D. Ghaith, M. Elzahry, G. Mostafa, S. Mostafa, R. Elsherif, and I. Ramzy, "Mutations affecting domain V of the 23S rRNA gene in Helicobacter pylori from Cairo, Egypt," J. Chemother., vol. 28, pp. 367-370, Oct 2016.

[53] A.I. Gunnarsdottir, H. Gudjonsson, H. Hardardottir, K.D. Jonsdottir, and E.S. Bjornsson, "Antibiotic susceptibility of Helicobacter pylori in Iceland," Infect. Dis. (Lond)., vol. 49, pp. 647-654, Sep 2017.

[54] V. De Francesco, A. Zullo, E. Ierardi, F. Giorgio, F. Perna, C. Hassan, S. Morini, C. Panella, and D. Vaira, "Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits," J. Antimicrob. Chemother., vol. 65, pp. 327-332, Feb 2010.

[55] M. Miftahussurur, A.F. Syam, I.A. Nusi, D. Makmun, L.A. Waskito, L.H. Zein, F. Akil, W.B. Uwan, and D. Simanjuntak, "Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations," PLoS One, vol. 11, pp. e0166199, 2016.

[56] N.R. Hussein, I. Tunjel, H.S. Majed, S.T. Yousif, S.I. Aswad, and M.S. Assafi, "Duodenal ulcer promoting gene 1 (dupA1) is associated with A2147G clarithromycin-resistance mutation but not interleukin-8 secretion from gastric mucosa in Iraqi patients," New Microbes New Infect., vol. 6, pp. 5-10, Jul 2015.

[57] K. Ben Mansour, C. Burucoa, M. Zribi, A. Masmoudi, S. Karoui, L. Kallel, S. Chouaib, S. Matri, and M. Fekih, "Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study," Ann. Clin. Microbiol. Antimicrob., vol. 9, pp. 22, Aug 13 2010.

[58] M.S. Alfaresi and A.A. Elkoush, "Characterization of clarithromycin resistance in isolates of Helicobacter pylori from the UAE," Indian J. Gastroenterol., vol. 29, pp. 116-120, Jun 2010.

[59] S. Agudo, G. Perez-Perez, T. Alarcon, and M. Lopez-Brea, "High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain," J. Clin. Microbiol., vol. 48, pp. 3703-3707, Oct 2010.

[60] T. Regnath, O. Raecke, A. Enninger, and R. Ignatius, "Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany," Helicobacter, vol. 22, Feb 2017.

[61] K. Murakami, T. Furuta, T. Ando, T. Nakajima, Y. Inui, T. Oshima, T. Tomita, K. Mabe, and M. Sasaki, "Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan," J. Gastroenterol., vol. 48, pp. 1128-1135, Oct 2013.

[62] P. Gonzalez-Hormazabal, M. Musleh, S. Escandar, H. Valladares, E. Lanzarini, V.G. Castro, L. Jara, and Z. Berger, "Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa," BMC. Gastroenterol., vol. 18, pp. 91, Jun 20 2018.

[63] N. Pastukha, A. Peretza, D. Brodskya, N. Isakovicha, M. Azrada and A. Onb. "Antimicrobial Susceptibility Of Helicobacter Pylori Strains Isolated From children in Israel," JGAR, vol. 12, pp. 175–178, 2018.

[64] M. Goudarzi, M. Heidary, M. Azad, M. Fazeli and H. Goudarzi. " Evaluation of antimicrobial susceptibility and integron carriage in Helicobacter pylori isolates from patients," Gastroenterol. Hepatol. Bed. Bench., vol. 9, pp. S47–S52, 2016.

[65] N. Bouihat, C. Burucoa, A. Benkirane, H. Seddik, S. Sentissi, A. Al Bouzidi, M. Elouennas, A. Benouda. "Helicobacter pylori primary antibiotic resistance in 2015 in Morocco: a phenotypic and genotypic prospective and multicenter study," Microb. Drug. Resist., vol. 23, no. 6, pp. 727 – 732, 2016.

[66] W. Wu, Y. Yang and G. Sun. " Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication. Review article," Gastroenterol. Res. Pract., vol. 2012, pp. 723183, 2012.

[67] C.A. Fallone, N. Chiba, S.V. van Zanten, L. Fischbach, J.P. Gilbert and R.H. Hunt. "The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults," Gastroenterology, vol. 151, no. 1, pp. 51 – 69, Jul. 2016.

[68] L. Boyanova, G. Gergova, I. Evstatiev, Z. Spassova, N. Kandilarov, P. Yaneva, R. Markovska, I. Mitov. " Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria, " Infect. Dis. (Lond)., vol. 48, pp. 56 – 62, 2016.

[69] M. Hakemi Vala, S. Eyvazi, H. Goudarzi, H.R. Sarie and M. Gholami. Evaluation of Clarithromycin Resistance Among Iranian Helicobacter pylori Isolates by E-Test and Real-Time Polymerase Chain Reaction Methods. Jundishapur. J. Microbiol., vol. 9, no.5, pp. e29839, 2016.

[70] V. De Francesco, F. Giorgio, E. Ierardi, M. Zotti, M. Neri, A. Milano, V. Varasano, F. Luzza, E. Suraci, R. Marmo, A. Marone, R. Manta, V.G. Mirante, M. de Matthaeis, A. Pedroni, G. Manes, S. Pallotta, P. Usai, M. Liggi, G. Gatto, V. Peri, R. Sacco, G. Bresci, F. Monica, C. Hassan and A. Zullo. " Primary clarithromycin resistance in Helicobacter pylori: the Multicentric Italian Clarithromycin Resistance Observational (MICRO) study, " J. Gastrointestin. Liver Dis., vol. 20, no. 3, pp. 235 – 239, 2011.

[71] F.T. Naserpour, R. Najafipour and P. Johari. " Prevalence of clarithromycin-resistant Helicobacter pylori in patients with chronic tonsillitis by allele-specific Scorpion real-time polymerase chain reaction assay, " Laryngoscope, vol. 123, no. 6, pp. 1478 – 1482, 2013.